- Practice your BIIB trading strategies and win cash in our stock game.
NEW YORK ( TheStreet) -- Biogen Idec Inc (Nasdaq: BIIB) hit a new 52-week high Monday as it is currently trading at $109.69, above its previous 52-week high of $109.63 with 1.7 million shares traded as of 2:55 p.m. ET. Average volume has been 2.1 million shares over the past 30 days. Biogen Idec has a market cap of $24.7 billion and is part of the health care sector and drugs industry. Shares are up 62.3% year to date as of the close of trading on Friday. Biogen Idec Inc., a biotechnology company, discovers, develops, manufactures, and markets therapeutics in the areas of neurology, immunology, hemophilia, and oncology in the United States and internationally. The company has a P/E ratio of 23.1, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.